Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Can J Cardiol ; 33(4): 437-442, 2017 04.
Artículo en Inglés | MEDLINE | ID: mdl-28110802

RESUMEN

BACKGROUND: Implantable cardioverter defibrillators (ICDs) have shown benefit in reducing mortality in patients with heart failure, after myocardial infarction, and those with reduced ejection fraction. We sought to explore the use of this therapy in specialized heart function clinics, in rural and urban locations. METHODS: This was a retrospective cohort study performed in 3 specialized heart function clinics in Nova Scotia, 2 of which were in rural locations. All patients with an initial left ventricular ejection fraction ≤ 35% were included from 2006 to 2011. Rates of referral, ICD implantation, and mortality were compared between urban and rural groups. RESULTS: There were 922 patients included in the study; 636 patients in the urban clinic, 286 in the rural locations. Referral rates were higher in the urban clinic compared with the rural locations (80.4% vs 68.3%; P = 0.024). Refusal rates for referral were higher in the rural locations (13.7% vs 2.1%; P < 0.0001). Higher referral rates were associated with urban location (odds ratio [OR], 1.81; 95% confidence interval [CI], 1.01-3.26; P = 0.047), and younger age (OR, 0.96; 95% CI, 0.93-0.99; P = 0.003); lower referral rates for women was observed (OR, 2.29; 95% CI, 1.13-4.63; P = 0.021). Mortality was significantly associated with older age, lack of referral, presence of comorbidities (renal failure, diabetes, peripheral vascular disease) and a rural location. CONCLUSIONS: Specialized heart function clinics have a high rate of appropriate referral for primary prevention ICDs, but referral rates for this life-saving therapy remain lower in rural jurisdictions. This disparity in access to care is associated with increased mortality and might require particular attention to prevent unnecessary deaths.


Asunto(s)
Muerte Súbita Cardíaca/prevención & control , Desfibriladores Implantables , Prevención Primaria/métodos , Población Rural , Población Urbana , Anciano , Muerte Súbita Cardíaca/epidemiología , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Masculino , Nueva Escocia/epidemiología , Oportunidad Relativa , Estudios Retrospectivos , Factores de Riesgo , Tasa de Supervivencia/tendencias
2.
Int J Parasitol ; 35(2): 225-33, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15710443

RESUMEN

Trypanosoma cruzi, the causative agent of Chagas disease, has at least two principal intraspecific subdivisions, T. cruzi I (TCI) and T. cruzi II (TCII), the latter containing up to five subgroups (a-e). Whilst it is known that TCI predominates from the Amazon basin northwards and TCII to the South, where the disease is considered to be clinically more severe, the precise clinical and evolutionary significance of these divisions remains enigmatic. Here, we present compelling evidence of an association between TCI and opossums (Didelphis), and TCII and armadillos, on the basis of key new findings from the Paraguayan Chaco region, together with a comprehensive analysis of historical data. We suggest that the distinct arboreal and terrestrial ecologies, respectively, of these mammal hosts provide a persuasive explanation for the extant T. cruzi intraspecific diversity in South America, and for separate origins of Chagas disease in northern South America and in the southern cone countries.


Asunto(s)
Armadillos/parasitología , Enfermedad de Chagas/transmisión , Didelphis/parasitología , Trypanosoma cruzi/aislamiento & purificación , Animales , Vectores de Enfermedades , Enfermedades Endémicas/veterinaria , Genotipo , Interacciones Huésped-Parásitos , Humanos , Insectos Vectores/parasitología , Paraguay , Triatominae/parasitología , Trypanosoma cruzi/fisiología
3.
Nature ; 421(6926): 936-9, 2003 Feb 27.
Artículo en Inglés | MEDLINE | ID: mdl-12606999

RESUMEN

The kinetoplastid Protozoa are responsible for devastating diseases. In the Americas, Trypanosoma cruzi is the agent of Chagas' disease--a widespread disease transmissible from animals to humans (zoonosis)--which is transmitted by exposure to infected faeces of blood-sucking triatomine bugs. The presence of genetic exchange in T. cruzi and in Leishmania is much debated. Here, by producing hybrid clones, we show that T. cruzi has an extant capacity for genetic exchange. The mechanism is unusual and distinct from that proposed for the African trypanosome, Trypanosoma brucei. Two biological clones of T. cruzi were transfected to carry different drug-resistance markers, and were passaged together through the entire life cycle. Six double-drug-resistant progeny clones, recovered from the mammalian stage of the life cycle, show fusion of parental genotypes, loss of alleles, homologous recombination, and uniparental inheritance of kinetoplast maxicircle DNA. There are strong genetic parallels between these experimental hybrids and the genotypes among natural isolates of T. cruzi. In this instance, aneuploidy through nuclear hybridization results in recombination across far greater genetic distances than mendelian genetic exchange. This mechanism also parallels genome duplication.


Asunto(s)
Recombinación Genética/genética , Trypanosoma cruzi/genética , Animales , ADN de Cinetoplasto/genética , ADN Mitocondrial/genética , Resistencia a Medicamentos/genética , Duplicación de Gen , Genoma , Genotipo , Pérdida de Heterocigocidad , Datos de Secuencia Molecular , Fenotipo , Filogenia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA